Alexander Viloria Winnett

Author

California Institute of Technology ORCID

Also Known As

Alexander Viloria Winnett, Alexander Winnett, Steven Gordon, Winnett, Alexander Viloria

Publications

485

Citations

H-Index

Concepts

All Affiliations

California Institute of Technology Pasadena City College University of California, Los Angeles Agency for Science, Technology and Research Experimental Drug Development Centre

About

Alexander Viloria Winnett is an author at California Institute of Technology specializing in vaccination, virology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	73
2	Immunology	2	2	62
3	Immunotherapy	2	2	62
4	Antibody Engineering	1	1	33
5	Covid-19	1	1	11

Alexander Viloria Winnett

Publications

434

Citations

H-Index

Page 1

	Year	Citations
Universal and Serial Laboratory Testing for SARS-CoV-2 at a Long-Term Care Skilled Nursing Facility for Veterans — Los Angeles, California, 2020 Amy V. Dora, Alexander Viloria Winnett, Lauren P. Jatt, MMWR Morbidity and Mortality Weekly Report	2020	132
Quantitative SARS-CoV-2 Viral-Load Curves in Paired Saliva Samples and Nasal Swabs Inform Appropriate Respiratory Sampling Site and Analytical Test Sensitivity Required for Earliest Viral Detection Emily S. Savela, Alexander Viloria Winnett, Anna E. Romano, Journal of Clinical Microbiology	2021	92
Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein Yadunanda Budigi, Eugenia Z. Ong, Luke N. Robinson, PLoS neglected tropical diseases VaccinationDengue VirusDengue E ProteinImmunologyDomain Iii	2018	33
SARS-CoV-2 Viral Load in Saliva Rises Gradually and to Moderate Levels in Some Humans Alexander Viloria Winnett, Matthew M. Cooper, Natasha Shelby,	2020	30
Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection Emily S. Savela, Alexander Viloria Winnett, Anna E. Romano,	2021	30
Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates Eugenia Z. Ong, Yadunanda Budigi, Hwee Cheng Tan, Antiviral Research VaccinationHuman IggsDengue VirusViral PathogenesisImmunology	2017	29
Extreme differences in SARS-CoV-2 viral loads among respiratory specimen types during presumed pre-infectious and infectious periods Alexander Viloria Winnett, Reid Akana, Natasha Shelby, PNAS Nexus	2023	27
Morning SARS-CoV-2 Testing Yields Better Detection of Infection Due to Higher Viral Loads in Saliva and Nasal Swabs upon Waking Alexander Viloria Winnett, Michael K. Porter, Anna E. Romano, Microbiology Spectrum	2022	17
Daily SARS-CoV-2 Nasal Antigen Tests Miss Infected and Presumably Infectious People Due to Viral Load Differences among Specimen Types Alexander Viloria Winnett, Reid Akana, Natasha Shelby, Microbiology Spectrum	2023	12
Widespread severe acute respiratory coronavirus virus 2 (SARS-CoV-2) laboratory surveillance program to minimize asymptomatic transmission in high-risk inpatient and congregate living settings Lauren P. Jatt, Alexander Viloria Winnett, Christopher J. Graber, Infection Control and Hospital Epidemiology VaccinationVirus EpidemiologyViral DiagnosticsLaboratory Surveillance ProgramRespiratory Diseases	2020	11

Page 1